Literature DB >> 18727894

[Etanercept as a possible trigger of fatal pulmonary fibrosis].

Juan M Díez Piña1, Oscar Vázquez Gómez, Sagrario Mayoralas Alises, José D García Jiménez, Dolores Alvaro Alvarez, M Paz Rodríguez Bolado.   

Abstract

Pulmonary fibrosis can be caused by external agents, including certain drugs. For some time now, tumor necrosis factor antagonists such as etanercept have been used to treat certain autoimmune diseases. Fibrosis caused by medication responds to withdrawal of the drug and treatment with corticosteroids. Very rarely, fibrosis is irreversible. We present the case of a patient who developed pulmonary fibrosis after initiating treatment with etanercept. The clinical course was fulminant despite withdrawal of the drug and high doses of corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18727894     DOI: 10.1016/s1579-2129(08)60067-1

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  1 in total

1.  Early instauration granulomatous pneumonitis associated with use of etanercept in seronegative spondyloarthropathy: Case report.

Authors:  Liliana Fernández-Trujillo; María B Iriarte; Germán Puerta; Eliana I Morales; Luz F Sua; Carlos A Cañas
Journal:  Respir Med Case Rep       Date:  2020-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.